https://scholars.lib.ntu.edu.tw/handle/123456789/551890
標題: | Primary Tumor Resection Is Associated with a Better Outcome among Advanced EGFR-Mutant Lung Adenocarcinoma Patients Receiving EGFR-TKI Treatment | 作者: | Tseng, Jeng-Sen Hsu, Kuo-Hsuan Zheng, Zhe-Rong Yang, Tsung-Ying Chen, Kun-Chieh Huang, Yen-Hsiang KANG-YI SU SUNG-LIANG YU Chang, Gee-Chen |
關鍵字: | Epidermal growth factor receptor; Epidermal growth factor receptor-tyrosine kinase inhibitor; Local ablative therapy; Lung adenocarcinoma; Primary tumor resection | 公開日期: | 2021 | 出版社: | KARGER | 卷: | 99 | 期: | 1 | 起(迄)頁: | 32 | 來源出版物: | Oncology | 摘要: | The characteristics and efficacy of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) in advanced EGFR-mutant lung adenocarcinoma patients with primary tumor resection (PTR) is not yet clear. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/551890 | ISSN: | 0030-2414 | DOI: | 10.1159/000509664 | SDG/關鍵字: | bevacizumab; epidermal growth factor receptor kinase inhibitor; erlotinib; gefitinib; protein tyrosine kinase inhibitor; EGFR protein, human; epidermal growth factor receptor; protein kinase inhibitor; ablation therapy; adult; advanced cancer; aged; Artic |
顯示於: | 醫學檢驗暨生物技術學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。